Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

F9 ±âÇü¾ÏÁ¾¼¼Æ÷ÀÇ ºÐÈ­À¯µµ ±âÀÛ¿¡ À־ Fos ´Ü¹éÁúÀÇ ±â´É¿¡ °üÇÑ ¿¬±¸ The Role of Fos Oncogene Protein on the Induction of Differentiation of F9 Teratocarcinoma Cells

´ëÇѾÏÇÐȸÁö 1993³â 25±Ç 1È£ p.47 ~ 53
¹è¼ö°æ, °­Ã¢¸ð, ¹Úº´Ã¤, ±è±Ô¿ø,
¼Ò¼Ó »ó¼¼Á¤º¸
¹è¼ö°æ (  ) 
ºÎ»ê´ëÇб³

°­Ã¢¸ð (  ) 
ºÎ»ê´ëÇб³
¹Úº´Ã¤ (  ) 
ºÎ»ê´ëÇб³
±è±Ô¿ø (  ) 
ºÎ»ê´ëÇб³

Abstract

¹ÌºÐÈ­»óÅÂÀÇ F9±âÇü¾ÏÁ¾¼¼Æ÷µéÀº fos ¾ÏÀ¯ÀüÀÚÀÇ ¹ßÇöÀÌ ¸Å¿ì ³·Àºµ¥ ºñÇØ ºÐÈ­Àΰ¡ÀÎ ·¹Æ¼³ëÀÍ»êÀ¸·Î 󸮸¦ ÇÏ¿© Á¤»óÀûÀÎ endoderm ¼¼Æ÷·Î ºÐÈ­·Î À¯µµ½ÃÅ°¸é fos ¾ÏÀ¯ÀüÀÚÀÇ ¹ßÇöÀÌ Áõ°¡¸¦ ÇÑ´Ù. ÀÌ fos ¾ÏÀ¯ÀüÀÚ°¡ F9 ±âÇü¾ÏÁ¾ÀÇ ºÐÈ­°úÁ¤¿¡¼­ ¾î¶² ¿ªÇÒÀ»
ÇÏ´ÂÁö
Á¶»çÇϱâ À§ÇÏ¿© fos ¹× neo¹ßÇöº¤ÅÍ·Î cotransfection ½ÃÄ×´Ù. ÀÌ transfectantµé¿¡¼­ ¸ÕÀú ÇüÅÂÀûÀÎ º¯È­°¡ °üÂûµÇ¾úÀ¸¸ç, in situ hybridization¿¡ ÀÇÇØ fos ¹ßÇöÀÌ Áõ°¡µÇ¾úÀ½À» È®ÀÎÇÏ¿´´Ù. ±×·±´ÙÀ½ ºÐÈ­ÀÎÀÚÀÎ ·¹Æ¼³ëÀÍ»ê°ú dbcAMP¸¦ °°ÀÌ Ã³¸®ÇÑ °á°ú
ºÐÈ­À¯µµ°¡
ÃËÁøµÇ¾ú´Ù. ¶ÇÇÑ F9 ±âÇü¾ÏÁ¾ ¼¼Æ÷´Â ·¹Æ¼³ëÀÍ»êÀ» ó¸®ÇÏÁö ¾Ê°í dibutyryl cAMP-theophylline(CT) ´Üµ¶ 󸮽ÿ¡´Â º¯È­¸¦ ³ªÅ¸³»Áö¾ÊÁö¸¸ neo/fos ÇüÁúÀüȯ F9 ¼¼Æ÷ÀÇ °æ¿ì´Â CT, ´Üµ¶ 󸮿¡ ÀÇÇؼ­µµ ºÐÈ­µÈ ¾ç»óÀ» ³ªÅ¸³»¾ú´Ù. ÀÌ °á°ú¿¡ ÀÇÇØ Fos ´Ü¹éÁúÀÌ
·¹Æ¼³ëÀÍ»ê°ú À¯»çÇÑ ºÐÈ­À¯µµ±â´ÉÀ» °¡Áö°í À־ CT ´Üµ¶ 󸮸¸À¸·Îµµ ºÐÈ­°¡ À¯µµµÇ¾îÁö´Â °ÍÀ¸·Î »ç·áµÈ´Ù.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS